| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18790532 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 101 journal articles in the PubMed database | Email to a friend | | |
| Kim H, Min YJ, Baek JH, et al.
A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome. [JOURNAL ARTICLE]
Leuk Res 2008 Sep 12.
Abstract | Full Citation | Find Related Articles | | Plosker GL, Figgitt DP
Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. [Clinical Trial, Journal Article, Randomized Controlled Trial, Review]
Drugs 2003; 63(8):803-43.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Rzepecki P, Sarosiek T, Szczylik C
Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience. [Journal Article]
Jpn J Clin Oncol 2006 Jan; 36(1):46-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Führer M, Burdach S, Ebell W, et al.
Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group. [Journal Article]
Klin Padiatr 1998 Jul-Aug; 210(4):173-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tötterman TH, Höglund M, Bengtsson M, et al.
Treatment of pure red-cell aplasia and aplastic anaemia with ciclosporin: long-term clinical effects. [Journal Article]
Eur J Haematol 1989 Feb; 42(2):126-33.
Abstract | Full Citation | Find Related Articles | | Rosenfeld S, Follmann D, Nunez O, et al.
Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. [Clinical Trial, Journal Article]
JAMA 2003 Mar 5; 289(9):1130-5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lundin J, Kimby E, Björkholm M, et al.
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL). [Clinical Trial, Clinical Trial, Phase II, Journal Article]
Blood 2002 Aug 1; 100(3):768-73.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tsiara SN, Chaidos A, Gouva M, et al.
Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone. [Journal Article]
J Exp Clin Cancer Res 2004 Mar; 23(1):47-52.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ahn MJ, Choi JH, Lee YY, et al.
Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial. [Clinical Trial, Journal Article, Multicenter Study]
Int J Hematol 2003 Aug; 78(2):133-8.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
